On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Yen‐Ting Lin

ResearcherPublications, citations & collaboration network

Yen‐Ting Lin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Yen‐Ting Lin have?

ScholarIQindexed works

Yen‐Ting Lin has 108 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Yen‐Ting Lin have?

ScholarIQcitation count

Yen‐Ting Lin has 1,028 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Yen‐Ting Lin?

ScholarIQh-index

Yen‐Ting Lin has an h-index of 17 in OpenAlex.

What is the i10-index of Yen‐Ting Lin?

ScholarIQi10-index

Yen‐Ting Lin has an i10-index of 31 in OpenAlex.

What is the OpenAlex record for Yen‐Ting Lin?

ScholarIQopenalex

The OpenAlex for Yen‐Ting Lin is on the source record.

What are the most-cited papers on Yen‐Ting Lin?

ScholarIQmost cited works
Stage Shift Improves Lung Cancer Survival: Real-World Evidence
Ching‐Yao Yang, Yen‐Ting Lin, Li‐Ju Lin, Ya‐Hsuan Chang, Hsuan‐Yu Chen, Yipin Wang, Jin‐Yuan Shih, Chong‐Jen Yu, Pan‐Chyr Yang
Journal of Thoracic Oncology. 202289 CitationsOPEN ACCESS
Infective endocarditis in children without underlying heart disease
Yen‐Ting Lin, Kai‐Sheng Hsieh, Yao-Shen Chen, I‐Fei Huang, Ming‐Fang Cheng
Journal of Microbiology Immunology and Infection. 201270 Citations
Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non–Small-Cell Lung Cancer
Yen‐Ting Lin, Yu‐Fen Wang, James Chih‐Hsin Yang, Chong‐Jen Yu, Shang‐Gin Wu, Jin‐Yuan Shih, Pan‐Chyr Yang
Journal of Thoracic Oncology. 201465 CitationsOPEN ACCESS
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations
Yen‐Ting Lin, Jin‐Shing Chen, Wei‐Yu Liao, Chao‐Chi Ho, Chia‐Lin Hsu, Ching‐Yao Yang, Kuan‐Yu Chen, Jih‐Hsiang Lee, Zhong‐Zhe Lin, Jin‐Yuan Shih, James Chih‐Hsin Yang, Chong‐Jen Yu
International Journal of Cancer. 201865 CitationsOPEN ACCESS
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
Yen‐Ting Lin, Chi‐Lu Chiang, Jen‐Yu Hung, Mei–Hsuan Lee, Wu‐Chou Su, Shang‐Yin Wu, Yu‐Feng Wei, Kang-Yun Lee, Yen-Han Tseng, Jian Su, Hsin-Pei Chung, Chih-Bin Lin, Wen-Hui Ku, Tsai-Shin Chiang, Chao‐Hua Chiu, Jin‐Yuan Shih
European Journal of Cancer. 202144 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial